NPC intracellular cholesterol transporter 1
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La NPC1 gene provides instructions for making a protein that is located within the membrane of compartments in the cell called lysosomes and endosomes, which digest and recycle materials. While the exact function of this protein is unclear, it plays a role in the movement of cholesterol and other types of fats (lipids) within cells and across cell membranes.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La NPC1 gene provides instructions for making a protein that is located within the membrane of compartments in the cell called lysosomes and endosomes, which digest and recycle materials. While the exact function of this protein is unclear, it plays a role in the movement of cholesterol and other types of fats (lipids) within cells and across cell membranes.
Conditions referring to this gene or chromosome
Other names
Niemann-Pick disease, type C1
NPC
Related patient information and medicines

Patient information leaflet
Puis-je prendre Atorvastatine et Mirabegron ensemble ?
Taking these two medicines together may slightly increase the level of atorvastatin in your blood. This could potentially in... Why this happens Mirabegron peuvent slightly interfere with a protein (CYP3A4) and a transporter (P-gp) that the body uses to break down and remove atorvastatin. This means the atorvastatin stays in your system a bit longer.

Patient information leaflet
Analyses de sang
GTT. Blood clotting tests Blood clotting tests. Tests for inflammation Blood tests to detect inflammation. Blood cholesterol level High cholesterol. Immunology Antibody and antigen tests - such as checking for antibodies to certain viruses and germs (bacteria). Blood grouping Blood groups and types. TSH blood test Thyroid function tests - this.

Patient information leaflet
Puis-je prendre de l'Aspirine et du Nustendi ensemble ?
Additionally, if you are taking high doses of aspirin (over 325mg daily), there is a theoretical risk that it could interfere with how bempedoic acid works to lower your cholesterol. Why this happens Aspirin and bempedoic acid (one du active ingredients dans Nustendi) sont both processed by the same pathway in the kidneys (OAT3 transporter)..

Patient information leaflet
Puis-je prendre de l'Atorvastatine et de l'extrait de chardon-Marie ensemble ?
Prendre milk thistle with atorvastatin might increase the levels of the medication in your bloodstream. Avertissement This information is for general educational purposes only and should doit pas be relied upon as a substitute for professional medical advice. Always consult votre GP, pharmacist, or another qualified healthcare professional before making.

Patient information leaflet
Puis-je prendre Atorvastatine et Matcha ensemble ?
Drinking matcha while taking atorvastatin may slightly increase the levels of the medication in your blood. Some studies suggest that high amounts of green tea catechins can interfere with the proteins (transporters) that move atorvastatin in and out of cells, or slightly slow down the liver enzymes that break the drug down. ...in, such as.

Patient information leaflet
Puis-je prendre de l'Atorvastatine et des suppléments de fibres ensemble ?
Taking fibre supplements at the same time as atorvastatin peuvent lower the amount of medicine your body absorbs. Pourquoi cela se produit Fibre supplements (like psyllium husk or methylcellulose) can bind to the atorvastatin in your stomach or intestines, preventing it from entering your bloodstream. Our Vérificateur d'Interactions Médicamenteuses helps you check whether.
Lectures complémentaires et références
- NPC intracellular cholesterol transporter 1; MedlinePlus, National Library of Medicine.
- Fernandez-Valero EM, Ballart A, Iturriaga C, Lluch M, Macias J, Vanier MT, Pineda M, Coll MJ. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations. Clin Genet. 2005 Sep;68(3):245-54. doi: 10.1111/j.1399-0004.2005.00490.x.
- Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, Walsh Vockley C, Coppock DL, Pettit KM, Heidenreich RA, Meaney FJ. The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A. 2007 Jun 1;143A(11):1204-11. doi: 10.1002/ajmg.a.31735.
- Mengel E, Klunemann HH, Lourenco CM, Hendriksz CJ, Sedel F, Walterfang M, Kolb SA. Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis. 2013 Oct 17;8:166. doi: 10.1186/1750-1172-8-166.
- Mukherjee S, Maxfield FR. Lipid and cholesterol trafficking in NPC. Biochim Biophys Acta. 2004 Oct 11;1685(1-3):28-37. doi: 10.1016/j.bbalip.2004.08.009.
- Ory DS. The niemann-pick disease genes; regulators of cellular cholesterol homeostasis. Trends Cardiovasc Med. 2004 Feb;14(2):66-72. doi: 10.1016/j.tcm.2003.12.003.
- Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, Vanier MT, Pineda M. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013 Jan 16;8:12. doi: 10.1186/1750-1172-8-12.
- Scott C, Ioannou YA. The NPC1 protein: structure implies function. Biochim Biophys Acta. 2004 Oct 11;1685(1-3):8-13. doi: 10.1016/j.bbalip.2004.08.006.
- Sturley SL, Patterson MC, Balch W, Liscum L. The pathophysiology and mechanisms of NP-C disease. Biochim Biophys Acta. 2004 Oct 11;1685(1-3):83-7. doi: 10.1016/j.bbalip.2004.08.014.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

